Immune · Reference
Thymosin Alpha-1 for Men: What the Research Has Looked At, and What It Is Not
This page covers what thymosin alpha-1 is, what research has and has not looked at, the questions men most often ask (testosterone, TRT, training, sport), the cautions that matter, what a physician rules out first in men over 40, and how Pepti supplies it. The general reference is what is thymosin alpha-1, and the evidence benefit by benefit is in thymosin alpha-1 benefits.
Thymosin alpha-1 has not been studied in men specifically: its randomized trials over more than thirty years were in hepatitis B, hepatitis C, sepsis, melanoma and vaccine response, and none in the live research reports results separately for men. The trials are mixed, with consistent but very low certainty signals in hepatitis B and a negative result in the largest trial, 1,106 adults with sepsis, and there are no trials at all in healthy adults, which is the use most men ask about. It is an immune-signalling peptide, not a hormone, not a testosterone booster and not the recovery peptide TB-500. It is a compounded prescription injection and is not FDA approved.
This page covers what thymosin alpha-1 is, what research has and has not looked at, the questions men most often ask (testosterone, TRT, training, sport), the cautions that matter, what a physician rules out first in men over 40, and how Pepti supplies it. The general reference is what is thymosin alpha-1, and the evidence benefit by benefit is in thymosin alpha-1 benefits.
Thymosin Alpha-1 for Men
The short answer
| Question | What the live research shows | Strength of evidence |
|---|---|---|
| Has it been studied in men specifically? | No trial in the live research reports men separately | None |
| Chronic hepatitis B | 2026 Cochrane review, 10 trials, 1,349 people | Human, very low certainty |
| Sepsis | 361 people (2013), then 1,106 people (BMJ, 2025); the larger trial found no clear mortality benefit | Human; the best trial was negative |
| General immune support in healthy men | No trial | No direct evidence |
| Does it raise testosterone? | It acts on immune cells, not on any hormone axis | Not a testosterone booster |
| Does it help muscle or recovery? | No study describes it; that is TB-500, a different molecule | Not a recovery peptide |
| Alongside TRT | No study of the combination | None |
| Tested sport | Not named on the 2026 WADA list, but the S0 class covers unapproved substances | Confirm with your governing body |
The honest summary: a compound that is consistently well tolerated in trials, that measurably changes immune-cell counts, that has never been tested in the healthy men who ask about it, and that has nothing to do with hormones or training.
Thymosin Alpha-1 for Men
What thymosin alpha-1 is, in one paragraph
Thymosin alpha-1 is a 28-amino-acid peptide with an acetyl group on its N-terminus, cut by the body from a larger precursor called prothymosin alpha. It was first isolated in 1977 from a calf thymus preparation, and the thymus is where T cells mature, so everything studied since has been about what it does to immune cells. In cell and animal work it acts on Toll-like receptors on dendritic cells, promotes T-cell maturation and, in some settings, pushes the response toward regulatory T cells, which is why a 2010 review called it "the regulator of regulators." Its generic name is thymalfasin, and a branded version has been sold since the 1990s in a number of countries outside the US; it has never been approved by the FDA. It is not a hormone, not a steroid, not an antiviral and not an immunosuppressant.
Thymosin Alpha-1 for Men
What research has looked at
The disease trials
This is a larger human trial record than almost any other compounded peptide has.
Indication Trial Result Chronic hepatitis B 1998 RCT in Hepatology, 98 patients; 2026 Cochrane review of 10 trials Signals of benefit, graded very low certainty Chronic hepatitis C 2012 RCT, 552 people No difference from placebo Severe sepsis 2013 ETASS trial, 361 people 26.0% against 35.0% mortality, marginal significance Sepsis 2025 TESTS trial in the BMJ, 1,106 adults 23.4% against 24.1%; no clear mortality benefit Metastatic melanoma 2010 RCT, 488 people, with chemotherapy A signal that did not reach significance Severe COVID-19 2020 retrospective review, 76 people Not confirmed by later randomized work What it shows. A peptide that has been through real trials, with mixed results, and that is consistently well tolerated: the trials, including the 1,106-patient sepsis trial, report adverse-event rates similar to placebo.
What it does not show. Any benefit in a healthy man. Every trial above was in a diagnosed disease, and none in the live research reports findings by sex.
T-cell counts in people
A 2020 report on severe COVID-19 measured a rise in circulating CD4 and CD8 T cells in treated patients. It is one of the few peptide mechanisms with a human laboratory readout. A change in a cell count is a laboratory endpoint, and often it would not be something anyone could feel.
Healthy adults
There are no randomized trials of thymosin alpha-1 for immune support in otherwise healthy adults, for frequent infections, for long COVID or for chronic fatigue. That use rests on clinical judgement, not on the trials.
Thymosin Alpha-1 for Men
What changes for men
It is not a testosterone booster
Thymosin alpha-1 acts on immune signalling. It is not a hormone and is not described as acting on testosterone or any hormone axis. If low testosterone is the question, peptides for testosterone covers what has and has not been studied.
It is not TB-500
The names cause constant confusion. TB-500 is a fragment of thymosin beta-4, an actin-binding protein studied around tissue repair, and it is what men looking for help with a tendon or old injury usually mean. Thymosin alpha-1 is a different molecule with a different job, and nothing in its research describes muscle, strength, tendon repair or training recovery. See thymosin alpha-1 vs TB-500 and TB-500 for men.
Alongside testosterone therapy
No study has looked at thymosin alpha-1 alongside testosterone replacement, and no interaction is described, but there is no established interaction list for it at all. List your testosterone prescription and whoever manages it on your intake so your physician can review them together. The wider picture is in can you take peptides with testosterone.
Autoimmune disease and immunosuppression
This is the caution that matters most, for men and women alike. Because thymosin alpha-1 acts on immune signalling, and immune modulation can go either way, a diagnosed autoimmune disease or any immunosuppressive treatment, for example after a transplant or for an inflammatory condition, needs specialist input before it is prescribed. No such reaction is documented in the trials, but this is the line not to argue around.
Fertility
Nothing in the live research looks at thymosin alpha-1 and male fertility in either direction. If conception is a goal, raise it with your physician before starting. See do peptides affect fertility.
Tested sport
Thymosin alpha-1 is not named on the 2026 WADA Prohibited List, but the S0 class covers substances without regulatory approval for human therapeutic use, and it has no FDA approval. Men in a tested sport should confirm with their governing body before starting. See peptides for athletes.
Thymosin Alpha-1 for Men
Men over 40: what a physician rules out first
Men often come to an immune peptide because they feel run down or seem to catch everything. That complaint usually has ordinary causes that come before immunity.
| What it is | How it shows up | Why it comes first |
|---|---|---|
| Obstructive sleep apnoea | Snoring, waking unrefreshed, daytime exhaustion | Destroys deep sleep and lowers testosterone; a sleep problem, not an immune one |
| Thyroid disease | Fatigue, weight change, cold intolerance | Common, findable, not treated by a peptide |
| Iron or B12 problems | Fatigue, brain fog | Findable and directly treatable |
| Metabolic causes, early diabetes | Fatigue, thirst, central weight | Its own treatment |
| A diagnosed immune condition | Repeated serious infections | A specialist question with established therapies |
More is in peptides for energy and fatigue, peptides for immune support and peptides for men over 40.
Thymosin Alpha-1 for Men
Side effects
Nothing in the live research suggests the profile differs between men and women.
| What is reported or relevant | When | What to do |
|---|---|---|
| Injection-site redness, mild soreness, occasional bruising | Any time | Rotate sites |
| Changes that may be immune-related, particularly with an autoimmune condition | Any time | Raise autoimmune disease or immunosuppression at intake; message your care team |
| A severe or spreading reaction, facial or throat swelling, difficulty breathing | Rare | Call 911 first, then tell your physician |
| Active cancer treatment, transplant, immunosuppression | Before treatment | Specialist input first |
The FDA's 2024 review raised immunogenicity from aggregated or impure compounded material, a manufacturing-quality question; lot test results are at /quality/lab-results. The full detail is in thymosin alpha-1 side effects.
Thymosin Alpha-1 for Men
Where thymosin alpha-1 stands with the FDA
Thymosin alpha-1 was placed in Category 2 of the FDA's interim 503A bulks list in 2023; the nomination was withdrawn and it was removed from Category 2 effective 27 September 2024. On 4 December 2024 the Pharmacy Compounding Advisory Committee voted 4 to 17 against adding it to the 503A Bulks List. That vote is a recommendation, not a rule; the FDA has not issued a final determination, and on the interim list updated 14 May 2026 it appears in no category. Compounded medications, thymosin alpha-1 included, are not FDA approved.
Thymosin Alpha-1 for Men
How Pepti supplies thymosin alpha-1
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| Thymosin Alpha-1, vial | 5 mL multi-dose vial, 2 mg/mL (10 mg) | 0.25 mL (25 units) subcutaneously once daily Monday through Friday; 0.5 mg per dose, 20 doses | $249/mo |
| Thymosin Alpha-1, Pen | 3 mL pre-filled Pen cartridge containing 15 mg | Dosed by dial, as printed with your prescription | See the product page |
| FORTIFY Blend | 5 mg thymosin alpha-1, 5 mg BPC-157, 2 mg KPV, 1 mg LL-37 in 5 mL | 0.25 mL (25 units) once daily Monday through Friday | $289/mo |
Twenty weekday doses is four weeks, so refills run every 28 days, one vial per fill. The arithmetic is in thymosin alpha-1 dosage. Pepti also supplies thymalin, a thymus extract with a Russian literature and no randomized trials; the comparison is in thymosin alpha-1 vs thymalin. Your physician sets your directions after reviewing your intake, and they are printed on the vial.
Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Vials arrive as ready-to-use multi-dose solutions with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs.
Thymosin Alpha-1 for Men
Where to get thymosin alpha-1 prescribed
Thymosin alpha-1 cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration, which matters for a peptide where one of the FDA's stated concerns was immunogenicity from impure material. The prescription route:
- Complete a free online intake covering your history, including any autoimmune, transplant or cancer history, your medications (including any testosterone), whether you are drug tested, and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your care team stays reachable for questions and side effects.
Step by step: how to get thymosin alpha-1 prescribed online. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
References
What this is based on.
References
- Dominari A, Hathaway Iii D, Pandav K et al.. Thymosin alpha 1: A comprehensive review of the literature · World J Virol (2020) · PMID 33362999
- Pierluigi B, D'Angelo C, Fallarino F et al.. Thymosin alpha1: the regulator of regulators? · Ann N Y Acad Sci (2010) · PMID 20536444
- Wu J et al.. The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial · BMJ (2025) · PMID 39814420
- Wu J et al.. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial · Crit Care (2013) · PMID 23327199
- Naing C et al.. Thymosin-ɑ1 for people with chronic hepatitis B · Cochrane Database Syst Rev (2026) · PMID 42713852
- Chien RN et al.. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trial · Hepatology (1998) · PMID 9581695
- Yang YF et al.. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis · Antiviral Res (2008) · PMID 18078676
- Ciancio A et al.. Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role? · J Viral Hepat (2012) · PMID 22233415
- Maio M et al.. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma · J Clin Oncol (2010) · PMID 20194853
- Liu Y et al.. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells · Clin Infect Dis (2020) · PMID 32442287
- Camerini R, Garaci E. Historical review of thymosin α 1 in infectious diseases · Expert Opin Biol Ther (2015) · PMID 26098768
- Gravenstein S, Duthie EH, Miller BA, Roecker E, Drinka P, Prathipati K, Ershler WB. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study · J Am Geriatr Soc (1989) · PMID 2642497
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Thymosin Alpha-1 for Men, answered.
It has not been studied in men specifically. Its trials were in diagnosed diseases, with mixed results, and none reports men separately. There are no trials in healthy adults, so any benefit for a healthy man is described, not established.
No. It acts on immune cells and is not described as acting on testosterone or any hormone.
Nothing in its research describes that. The recovery peptide with a similar name is TB-500, a fragment of thymosin beta-4, which is a different molecule.
No. Thymosin alpha-1 is a 28-amino-acid immune peptide; TB-500 is a seven-amino-acid fragment of thymosin beta-4 studied around tissue repair. See thymosin alpha-1 vs TB-500.
No interaction is described, but no study has looked at the combination. List your testosterone prescription and whoever manages it on your intake.
The research describes it as a modulator rather than a stimulant: it sharpens immune signalling in cell work and raised T-cell counts in one human report, but it has never been tested for immune support in healthy adults.
Anyone with an autoimmune disease or on immunosuppression, including after a transplant, needs specialist input first, and it is not used in pregnancy or breastfeeding. Active cancer treatment is also a specialist conversation.
It is not named on the 2026 WADA Prohibited List, but the S0 class covers substances without regulatory approval for human use. Confirm with your governing body before starting.
The same as for anyone: mostly injection-site redness or soreness. The trials report adverse-event rates similar to placebo. Facial or throat swelling or difficulty breathing needs 911.
At Pepti, the thymosin alpha-1 vial is $249 a month and the FORTIFY Blend is $289 a month, all-in, covering medication, physician review, refill management and shipping.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.